Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Degarelix Acetate for Injection

Approval Number

国药准字HJ20180053

CompanyFerring Pharmaceuticals A/S

Registration Date

March 1, 2024

Previous Approval Numbers

H20180053

Drug Information

Generic Name

注射用醋酸地加瑞克

Dosage Form

注射剂

Strength

120mg (按地加瑞克(C₈₂H₁₀₃N₁₈O₁₆Cl)计算)

Drug Type

化学药品

Registration Date

March 1, 2024

Expiry Date

February 28, 2029

Company Information

Applicant Company

Company NameFerring Pharmaceuticals A/S

Company Address

Amager Strandvej 405, 2770 Kastrup, Denmark

Manufacturing Company

Company NameFerring GmbH

Company Address

Wittland 11, 24109 Kiel, Germany

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

注射用醋酸地加瑞克 - NMPA 批准文号 | MedPath